Xalatan and Osteopenia - a phase IV clinical study of FDA data

Summary:

Osteopenia is reported as a side effect among people who take Xalatan (latanoprost), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lorazepam, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Osteopenia when taking Xalatan. It is created by eHealthMe based on reports of 25,196 people who have side effects when taking Xalatan from the FDA, and is updated regularly.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,550 Xalatan users. Check the latest studies of Xalatan.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,435 drugs and 1,172 conditions by eHealthMe. Check the latest studies of Osteopenia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

25,196 people reported to have side effects when taking Xalatan.
Among them, 70 people (0.28%) have Osteopenia.

Among these 70 people:

How long have people been on Xalatan when they have Osteopenia? *

What is the gender of people who have Osteopenia when taking Xalatan? *

female: 63.77 %
male: 36.23 %

What is the age of people who have Osteopenia when taking Xalatan? *

What are other drugs people take besides Xalatan? *

What are other side effects people have besides Osteopenia? *

Pain: 42 people, 60.00%
Joint Pain: 36 people, 51.43%
Fall: 33 people, 47.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 31 people, 44.29%
Constipation: 31 people, 44.29%
Osteonecrosis Of Jaw (death of bone of jaw): 31 people, 44.29%
Depression: 27 people, 38.57%
Insomnia (sleeplessness): 26 people, 37.14%
Gait Disturbance: 24 people, 34.29%
Dizziness: 24 people, 34.29%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 18 people, 25.71%
Pain: 17 people, 24.29%
Breast Cancer Metastatic: 13 people, 18.57%
Depression: 13 people, 18.57%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 13 people, 18.57%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 17.14%
Arrhythmias (irregular heartbeat): 10 people, 14.29%
Stable Angina (a constant chest pain): 10 people, 14.29%
High Blood Pressure: 9 people, 12.86%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 8 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Xalatan and have Osteopenia?

- Check whether Osteopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalatan:

Xalatan (25,550 reports)

Osteopenia treatments and more:

Osteopenia (46,948 reports)

Browse all side effects of Xalatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteopenia:

Osteopenia (1,435 drugs)

Browse all the conditions that are associated with Osteopenia:

Osteopenia (1,172 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Xalatan) and Xalatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.